Olema Pharmaceuticals's total assets for Q1 2026 were $530.64M, a decrease of -0.52% from the previous quarter. OLMA total liabilities were $50.17M for the fiscal quarter, a -8.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.